Abstract-In most rat models studied to date, increased ventricular mass is associated with high ventricular expression of the atrial natriuretic factor (ANF) gene. However, it is unknown whether ANF plays a beneficial or detrimental role in the course of left ventricular hypertrophy or whether ANF gene expression could be genetically linked to cardiac mass.
C ardiovascular diseases are the principal cause of mortality and morbidity in industrialized countries. In recent years, left ventricular hypertrophy (LVH) has emerged as a powerful independent risk factor for cardiovascular mortality and morbidity. 1, 2 To gain further knowledge about the causes and consequences of this condition, experimental animal models of LVH have been created either in rats [3] [4] [5] [6] [7] [8] or in several models of transgenic mice. 9 -13 Among other things, such models have made it possible to discover some of the biochemical alterations that typically associate with LVH, among which increased ventricular expression of atrial natriuretic factor (ANF) has emerged as one of the most consistent features. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Despite the tight association between ANF and experimentally induced LVH, several questions have remained unanswered. First, it is not known whether ventricular ANF plays any role in the course of LVH and whether such role would be beneficial or detrimental. Second, in all models of LVH where an increase of ventricular ANF has been reported, LVH resulted from the imposition of an exogenous stimulus. However, how ventricular ANF correlates with ventricular mass in the absence of increased workload and/or alteration of intracellular cardiac signaling is not known. This particular question is important in light of evidence showing either in rats 14 -18 or humans 19, 20 that factors other than blood pressure or workload may affect the development of LVH. It is pertinent to ask whether ventricular ANF may be one such factor and in which way it could affect cardiac mass.
We reasoned that cosegregation analyses in genetic crosses of inbred rats would provide a way to investigate whether there was a genetic link between ventricular ANF expression and cardiac mass. Ideally, we would need strains displaying quantitative differences in the abundance of ventricular ANF mRNA and in cardiac mass but no differences in terms of blood pressure. Some novel recombinant inbred rat strains that had been created from the progeny of F2 crosses of Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) constituted attractive candidates in this regard. 21, 22 The WKY-derived hyperactive (WKHA) strain is normotensive and exhibits increased behavioral activity in a novel environment as well as increased cardiovascular reactivity to stress compared with WKY rats, and its cardiac mass is higher than that of WKY. [21] [22] [23] Conversely, the WKY-derived hypertensive (WKHT) strain is hypertensive, its behavioral activity and cardiovascular reactivity to stress are not increased compared with WKY rats, and its cardiac mass is intermediary between that of WKY and SHR. [21] [22] [23] It has been verified that the WKHA and WKHT strains are truly inbred and that their genome truly represented mixes of the genomes of WKY and SHR. 22 However, there is no information on the ventricular abundance of ANF or other biochemical markers of LVH in these various strains. We therefore performed a systematic phenotypic characterization of these various strains to test whether some of them might be suitable for investigations involving genetic crosses.
Materials and Methods

Animals
Male SHR/Cr and WKY/Cr rats were obtained from Charles River (St-Constant, Québec, Canada) and are hereafter designated SHR and WKY. Male WKHA/Cfd and WKHT/Cfd were obtained from the colony that is maintained at the Institut de Recherches Cliniques de Montréal (IRCM). This colony was originated from breeding stock obtained from E.D. Hendley (Burlington, Vt) and has been registered with the Institute of Laboratory Animal Resources of the National Research Council. 22 The strains are hereafter designated WKHA and WKHT.
Generation of F2 animals involved the mating of male WKHA to female WKY rats. The resulting F1 animals were mated again randomly to generate F2 animals, of which a total of 162 males were used at 12 weeks of age for the purpose of the present experiments.
Animal Procedures
Animal procedures were approved by the IRCM Animal Care Committee and conducted according to the recommendations of the Canadian Council on Animal Care. For each strain, 6 animals were selected at the ages of 9, 12, 16, and 24 weeks. F2 animals were killed at the age of 12 weeks. One day before sacrifice, the animals were prewarmed to 37°C and then placed in an acrylic restrainer to measure systolic blood pressure by tail-cuff plethysmography.
On the day of tissue collection, each animal was first weighed for determination of whole-body weight. The rats were then killed by decapitation, the hearts were dissected out, trimmed at the atrioventricular junction, the ventricles were emptied of residual blood, and the block of tissue constituted by both ventricles was weighed to calculate the biventricular weight/body weight (VW/BW) ratio. For experiments performed on F2 animals, the ventricles were further dissected into right ventricle and left ventricle (which included the septal wall), and each part was weighed individually. The ventricles were further cut into pieces, frozen in liquid nitrogen, and kept at -70°C for further analysis.
RNA Analysis
Frozen fragments of tissue containing the free wall of the left ventricle were pulverized with a mortar and pestle in liquid nitrogen, and total RNA was extracted using a modification of the single-step acid guanidium thiocyanate-phenol-chloroform method. 24 Northern blot analyses were performed using the following probes: for ANF, the 800-bp EcoRI-HindIII fragment from the SP64-rANF plasmid 25 ; for GAPDH, the 1.2-kb EcoRI fragment from the American Type Culture Collection 78105 plasmid; for ␣-myosin heavy chain (␣-MHC), the oligonucleotide 5Ј-TTGTGGGATAGCAACAGCGA-3Ј; for ␤-myosin heavy chain (␤-MHC), the oligonucleotide 5Ј-GTCTCAGGGCTTCACAGG-3Ј; and for ␣-skeletal actin, the oligonucleotide 5Ј-GCAACCATAGCACGATGGTC-3Ј. Sequences for the oligonucleotides were as published previously. 5 The blots were hybridized to either cDNA or oligonucleotide probes labeled with [
32 P], similarly as previously described. 5, 26 After washing, the hybridized blots were exposed to a phosphorscreen cassette, and the signals were visualized and quantified using the ImageQuant software (Molecular Dynamics, Sunnyvale, Calif). Results were normalized by dividing the value for each sample by the intensity of either the corresponding 18S ribosomal band or the signal obtained by hybridization with the GAPDH probe. Comparisons between strains were performed by dividing each individual value by the mean of the values obtained for the samples of WKY rats of the same age group. Quantification of specific mRNAs in hearts from F2 animals required distributing the samples over 11 different blots. In these cases, the values were further normalized by including in each blot 2 samples of total RNA extracted from the ventricle of one reference WKY rat and dividing each specific ratio value by the mean value of the ratios obtained for the reference WKY samples from the same blot.
ANF Radioimmunoassay
Fragments of left ventricular apex (Ϯ200 mg) were weighed, powdered under liquid nitrogen, and boiled for 5 minutes in a volume of 2 mL of 0.2 mol/L acetic acid. The extracts were then centrifuged at 30 000g for 30 minutes. Aliquots of 5 L of supernatant were assayed, using the same procedures and reagents as described previously. 27 
Statistical Analysis
Data sets collected in different strains at different ages were analyzed by 2-way ANOVA, which tested the effect of strain, the effect of age, and whether there was an interaction between both factors. When significant differences were found, subsets of data were further tested by post hoc Fisher least-significance difference (LSD) tests. When comparisons were made between 2 groups, differences were analyzed by Student t test. Linear regression analysis was used to calculate the coefficient of correlation (r) between left ventricular weight and other variables; the level of significance of the correlation was then calculated by ANOVA. Figure 1 shows a representative example of ANF Northern analysis. This particular blot contains total RNA samples obtained from the left ventricle of all 4 strains of rats killed at 16 weeks of age. Although the intensity of the 18S ribosomal bands was comparable in all 4 groups, there were readily detectable differences in the intensity of the ANF signal of all 4 groups, the relative order of intensity being WKHA Ͻ WKY Ͻ SHR Ͻ WKHT. Additional measurements were performed first with WKY and WKHA rats at 9, 12, 16, and 24 weeks of age ( Figure 2 ). Systolic blood pressure was identical in both strains ( Figure  2A) ; no difference was detected by 2-way ANOVA. Comparisons of the VW/BW ratios ( Figure 2B ) across ages revealed that relative ventricular mass was significantly higher (PϽ0.001) in WKHA than in WKY rats, whereas there was no significant effect of age. The relative abundance of ventricular ANF mRNA ( Figure 2C ) was inverse to what had been observed with VW/BW values: ANF mRNA was significantly lower (PϽ0.001) in WKHA than in WKY rats, with no effect of age.
Results
Differences in ANF mRNA concentration were mirrored at the level of ANF peptide; the left ventricular concentration of ANF immunoreactivity in WKHA rats was about 30% of the levels found in WKY rats (Table 1) . Moreover, it was found by Northern blot analysis that the abundance of ␤-MHC and ␣-skeletal actin mRNAs was significantly higher in WKHA than in WKY rats, whereas there were no quantitative changes in the abundance of ␣-MHC mRNA (Table 1) .
To test whether low abundance of ventricular ANF mRNA and/or peptide would segregate with high ventricular mass in a genetic cross, we measured both variables in rats originating from a population of 162 male hybrid WKHA/WKY crosses. In these experiments, we measured left ventricular (instead of biventricular) weight, because parallel experiments had revealed that the ventricular weight difference between WKHA and WKY rats could be entirely accounted for by differences in the weight of left ventricles. Within the context of this segregating F2, we observed that the left ventricular concentrations of ANF mRNA and ANF peptide correlated inversely with left ventricular mass (Figure 3) . In contrast, the concentration of ␤-MHC RNA increased proportionately with left ventricular mass (Figure 3) . Linear regression analysis of the points from these data sets confirmed that all 3 correlations were statistically significant ( Table 2 ). Skeletal actin mRNA also tended to increase with left ventricular mass, but the association failed to reach statistical significance. Of note, the number of points analyzed did not always correspond exactly to the entire number of animals generated for the F2 population. For instance, there was not always enough ventricular tissue left for some animals from the F2 population to measure ANF immunoreactivity. In the Northern blot experiments, some membranes presented background problems that prevented accurate quantification of the corresponding autoradiograms.
Other comparisons were made between WKHT rats and SHR, which are both hypertensive ( Figure 4A ). The 2-way ANOVA revealed that systolic blood pressures from WKHT rats were not statistically different from that of SHR but that blood pressures increased significantly in both strains as a function of age (PϽ0.001). Comparisons of the VW/BW ratios ( Figure 4B ) across ages revealed that ventricular mass was significantly higher in SHR than in WKHT rats (PϽ0.0011) but that age had no significant effect. Similarly to what had been observed for the 2 normotensive strains, the relative abundance of ventricular ANF mRNA ( Figure 4C ) was inverse to what had been observed with VW/BW values: ANF mRNA was significantly lower in SHR than in WKHT rats (PϽ0.0038).
Discussion
Cardiac atria are the predominant source of production of circulating ANF. The canonical role of this hormone is to promote natriuresis by regulating renal blood flow and exerting a concerted action on several nephron segments. 28 Natriuretic peptides are also produced in fetal and neonatal ventricles, but their production greatly decreases during the postnatal period, and by the time the animal reaches adult age, ANF mRNA is much less abundant in ventricles than in atria. 25 Whereas ventricular ANF may increase when maneuvers are performed to induce LVH, it is not known whether it plays a particular role, if any, in the course of LVH, and whether such role would be beneficial or detrimental.
The availability of the WKHA inbred rat strain provided us with the opportunity to test whether ventricular ANF could be genetically linked to ventricular mass. WKHA and WKY rats are both normotensive, and ventricular mass is higher in WKHA than in WKY, yet ventricular ANF mRNA was All values are meanϮSEM; n indicates the number of rats used in each group. ANF immunoreactivity (ANF-IR) was measured by radioimmunoassay and is expressed as fmol/mg wet weight. All other values were obtained from Northern blot analysis; the values correspond to the ratios of the signal obtained with the specific cDNA probe to that obtained with the GAPDH probe. NS indicates not significant. consistently lower in WKHA than in WKY. Differences in ANF mRNA were mirrored by changes in the ventricular concentration of ANF peptide. Expression of the ANF gene in the ventricle may be governed by both mechanical and local humoral influences. 29 Given that the WKHA and WKY rats are both normotensive, it is unlikely that mechanical forces would be responsible for differences between the 2 strains.
Within the particular context of an F2 WKHA/WKY hybrid cross (where each individual animal has a unique and distinct genetic background), we found that low abundance of ventricular ANF (either peptide or mRNA) correlated with high ventricular mass. This finding is in contrast with previous reports, in which LVH had consistently been found to be accompanied by increases in the abundance of ANF mRNA. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Alternatively, one might conceive that enlarged ventricular walls in the absence of increased workload could reduce ventricular ANF via a reduction of wall stress. However, if this were the case, other markers of LVH would be expected to decrease as well. Our observations of ␤-MHC suggest the opposite. Furthermore, ventricular ANF has also been reported to be increased in exercised-induced LVH, which is also characterized by enlarged ventricular walls and reduced wall stress. 30, 31 This suggests that ANF ventricular expression is not always simply a reflection of wall stress.
One other explanation can be derived from recent data concerning the actions of ANF on cardiocytes. Ventricular cardiomyocytes constitute a legitimate target of natriuretic peptides, since they have been reported to contain the natriuretic peptide receptors NPR-A and NPR-B, and isolated myocytes produce cGMP when exposed to ANF or brain natriuretic peptide (BNP). 32 Both natriuretic peptides and cGMP (the presumed second messenger mediating most of the biological actions of natriuretic peptides 28 ) have been shown to have a variety of effects on cardiomyocytes, as they improve the relaxation properties of these cells, increase their susceptibility to arrhythmias, stimulate their rate of glycolysis, and reduce activity of L-type Ca 2ϩ channels. [33] [34] [35] [36] Furthermore, Yamamoto et al 37 have recently used in vivo inhibitors of the intracardiac endogenous natriuretic peptide system to show that local natriuretic peptides may have autocrineparacrine roles in the regulation of ventricular function. In vitro, several investigators have shown recently that ANF and/or cGMP have antigrowth effects on either neonatal cardiomyocytes or cardiac fibroblasts in culture. 38 -40 Finally, some investigators have produced mice in which the genes of either ANF or its corresponding receptor have been invalidated. 41, 42 In both cases, there is an increase in cardiac mass that is disproportionately large in comparison with the very modest increases in blood pressure found in these animals.
In light of such data, the action of ANF and/or cGMP may well be to protect the heart against hypertrophy. When LVH n indicates the number of rats used in each regression analysis; r, the coefficient of correlation; and P, the level of significance of the correlation. Comparisons between the abundance of ANF peptide, the abundance of ANF mRNA, and the abundance of ␤-MHC mRNA in male rats from a hybrid WKHA/ WKY F2 population. For graphic representation, the population was divided into 3 different tertiles: the lower tertile comprised the hearts whose LVW/BW ratio was below 2.6, the mid-tertile comprised the hearts whose ratio was between 2.6 and 2.8, and the higher tertile comprised the hearts whose ratio was higher than 2.8. Number in parentheses represents the number of rats in each group. Individual values from the same data sets were analyzed by linear regression ( Table 2) . O.D. indicates optical density. Figure 2 , and are shown for reference only). A, Systolic blood pressures as measured at different ages in both strains; values at 24 weeks were higher than at previous ages in both strains, but no differences were detected between the strains. B, Asterisks indicate which particular age groups had significant differences (PϽ0.05) in the VW/BW ratio, as assessed by the post hoc Fisher LSD tests. C, Relative ANF mRNA values were calculated by dividing each individual value by the mean of the values obtained for the samples of the WKY rats of the same age group. Asterisks indicate in which age groups the abundance of ANF mRNA in the ventricles of WKHT rats was higher than in the ventricles of SHR, as assessed by the post hoc Fisher LSD tests (PϽ0.05).
results from exogenous stimuli, ventricular ANF may increase as a counterregulatory mechanism to the stimulus. In contrast, when the relative amount of baseline ventricular ANF is decreased, there may be increased susceptibility to LVH. If this hypothesis is correct, one might predict that with a given level of increased blood pressure, the severity of LVH will be inversely proportional to the amplitude of the ventricular ANF response. Although we have not performed experiments addressing this question with WKHA rats, the data we have obtained in WKHT rats and SHR are suggestive in this regard. Indeed, both strains are equally hypertensive, and in both strains, ventricular ANF mRNA is higher than in normotensive WKY rats. However, the abundance of ventricular ANF mRNA is consistently higher in WKHT rats than in SHR, yet ventricular mass is lower in WKHT than in SHR. At the very least, this observation provides yet another novel example of when the magnitude of the LVH process can be dissociated from that of the ventricular ANF response. However, it also suggests that beyond baseline levels (as illustrated in WKHA and WKY rats), the amplitude of the ventricular ANF response (which is genetically determined) may also modulate the importance of the hypertrophic process to exogenous stimuli, ie, the environment.
In summary, we found by cosegregation analysis in genetic crosses that there was a genetic link between low ventricular ANF mRNA and high ventricular mass. Combined with recent reports indicating that ANF and/or cGMP may have antigrowth effects, our data are consistent with a protective role for endogenous ventricular ANF against LVH. This hypothesis is also compatible with experiments in SHR, showing that treatments that increase the ventricular concentration of ANF and/or cGMP also decrease LVH in the absence of any detectable effect on blood pressure. 43, 44 However, it is not possible to determine in these experiments whether the treatments affected cardiac mass by a direct effect on the ventricles or via peripheral effects. In future experiments, it will therefore be worthy to explore whether ventricular ANF may affect ventricular mass directly via local effects and to decipher the mechanisms of such actions.
